CA2759551C - Lipid-containing compositions and methods of use thereof - Google Patents

Lipid-containing compositions and methods of use thereof Download PDF

Info

Publication number
CA2759551C
CA2759551C CA2759551A CA2759551A CA2759551C CA 2759551 C CA2759551 C CA 2759551C CA 2759551 A CA2759551 A CA 2759551A CA 2759551 A CA2759551 A CA 2759551A CA 2759551 C CA2759551 C CA 2759551C
Authority
CA
Canada
Prior art keywords
formulation
oil
omega
fatty acids
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2759551A
Other languages
English (en)
French (fr)
Other versions
CA2759551A1 (en
Inventor
Urvashi Bhagat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asha Nutrition Sciences Inc
Original Assignee
Asha Nutrition Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asha Nutrition Sciences Inc filed Critical Asha Nutrition Sciences Inc
Publication of CA2759551A1 publication Critical patent/CA2759551A1/en
Application granted granted Critical
Publication of CA2759551C publication Critical patent/CA2759551C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
CA2759551A 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof Active CA2759551C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US4674708P 2008-04-21 2008-04-21
US61/046,747 2008-04-21
US7570808P 2008-06-25 2008-06-25
US61/075,708 2008-06-25
US11159308P 2008-11-05 2008-11-05
US61/111,593 2008-11-05
US12/426,034 2009-04-17
US12/426,034 US20090264520A1 (en) 2008-04-21 2009-04-17 Lipid-containing compositions and methods of use thereof
PCT/US2009/041114 WO2009131939A2 (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
CA2759551A1 CA2759551A1 (en) 2009-10-29
CA2759551C true CA2759551C (en) 2021-03-16

Family

ID=41201653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2759551A Active CA2759551C (en) 2008-04-21 2009-04-20 Lipid-containing compositions and methods of use thereof

Country Status (15)

Country Link
US (2) US20090264520A1 (enExample)
EP (2) EP3305083A1 (enExample)
JP (4) JP2011518223A (enExample)
KR (2) KR102038118B1 (enExample)
CN (1) CN102065699A (enExample)
AU (1) AU2009239499C1 (enExample)
BR (1) BRPI0910852A2 (enExample)
CA (1) CA2759551C (enExample)
CO (1) CO6321198A2 (enExample)
EA (1) EA201071206A1 (enExample)
IL (1) IL208858A (enExample)
MX (2) MX2010011544A (enExample)
MY (1) MY157040A (enExample)
WO (1) WO2009131939A2 (enExample)
ZA (1) ZA201008232B (enExample)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
EP2215913A1 (en) 2009-01-23 2010-08-11 Nutreco Nederland B.V. Animal feed additive and animal feed comprising alkyl esters of medium chain fatty acids, and their use in animal feed
FR2948025B1 (fr) 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3
CO6290096A1 (es) * 2009-12-30 2011-06-20 Team Foods Colombia Sa Esparcible con bajo contenido de grasa total hecho con aceites vegetales y fitoesteroles
BRPI1000759E2 (pt) * 2010-03-18 2015-09-15 Paulo Roberto Leitão De Vasconcelos preparado à base de óleos vegetais usado como suplemento nutricional
AU2011276545A1 (en) 2010-06-28 2012-12-13 Nestec S.A. Hypocaloric, high protein nutritional compositions and methods of using same
BR112013008699A2 (pt) * 2010-10-14 2016-06-21 Asha Nutrition Sciences Inc formulações nutricionais otimizadas, métodos para a seleção das dietas formuladas das mesmas, e os métodos de utilização das mesmas
US20120263809A1 (en) * 2011-03-29 2012-10-18 Andrew Baker Nutritional Supplement Comprising Nut and Seed Oil Composition
JP2013001666A (ja) * 2011-06-14 2013-01-07 Yasuharu Omura 栄養剤組成物
PL2731451T3 (pl) 2011-07-12 2019-03-29 Impossible Foods Inc. Sposoby i kompozycje dla produktów żywnościowych
CA2841473C (en) 2011-07-12 2020-08-11 Maraxi, Inc. Methods and compositions for consumables
US20140220217A1 (en) 2011-07-12 2014-08-07 Maraxi, Inc. Method and compositions for consumables
US10039306B2 (en) 2012-03-16 2018-08-07 Impossible Foods Inc. Methods and compositions for consumables
CN102550710A (zh) * 2011-11-23 2012-07-11 阳泉市万和油脂有限公司 一种核桃优配油
CN104254327A (zh) 2012-02-09 2014-12-31 诺格拉制药有限公司 治疗纤维化的方法
US20140087011A1 (en) * 2012-05-16 2014-03-27 Louise M. Smith RyWhe / The Drink of Life
AU2013277441B2 (en) 2012-06-17 2017-07-06 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
US20140065279A1 (en) * 2012-09-06 2014-03-06 Michael Roizen Edible oils for frying and cooking foods having health benefits
CN102845539A (zh) * 2012-09-19 2013-01-02 河南茗轩食品科技有限公司 一种亚麻膳食调和油及其制备方法
EP2716167A1 (en) * 2012-10-02 2014-04-09 Lunamed AG Non-pharmaceutical composition comprising short chain fatty acids
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
CN114847358A (zh) 2013-01-11 2022-08-05 非凡食品有限公司 包含凝聚物的非乳制干酪仿品
SMT201800107T1 (it) 2013-01-11 2018-05-02 Impossible Foods Inc Metodi e composizoni per influenzare il profilo di sapore e aroma di generi alimentari
TN2013000036A1 (fr) * 2013-01-29 2014-06-25 Guetari Sami Complement alimentaire omega 3 a base d'huile de poisson ameliore
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
SG11201507522XA (en) * 2013-03-12 2015-10-29 Hmi Medical Innovations Llc Plant extracts with anti-diabetic and other useful activities
CN103156195B (zh) * 2013-04-10 2015-07-29 饶攀 一种功能性食品组合物及其制备方法
FR3007418B1 (fr) * 2013-06-21 2015-07-17 Interoleagineuse D Assistance Et De Dev S I A Soc Composition lipidique a base de triacylglycerol
CN104247786A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合健康双合食用油
CN104247787A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合普健康经济型a级双合食用油
ES2528331B1 (es) * 2013-08-06 2015-12-02 Fundación Para La Investigación Biomédica Del Hospital Universitario Puerta Del Hierro Composición con efecto en la salud ósea y cardiovascular
CN104413170A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量25-30克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413167A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量35克以上人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413168A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量30-35克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN103404613A (zh) * 2013-08-22 2013-11-27 宁夏吴忠市国海粮油有限公司 一种葵花调和油及其加工工艺
CN105658084A (zh) * 2013-10-23 2016-06-08 英派尔科技开发有限公司 食品添加剂、食品包装添加剂及其用途
US9820484B2 (en) * 2013-12-04 2017-11-21 Nippon Suisan Kaisha, Ltd. Dihomo-γ-linolenic acid-containing microbial oil and dihomo-γ-linolenic acid-containing microbial biomass
CN103622023B (zh) * 2013-12-13 2015-12-09 许伯宗 一种前列腺保健品及其制备方法
CN103610835B (zh) * 2013-12-17 2015-07-15 刘凤阁 一种治疗眼底出血的药剂
WO2015112581A1 (en) 2014-01-21 2015-07-30 The Medical College Of Wisconsin, Inc. Methods for selective inhibition of pluripotent stem cells
WO2015153666A1 (en) 2014-03-31 2015-10-08 Impossible Foods Inc. Ground meat replicas
KR20180004096A (ko) * 2014-07-11 2018-01-10 매뉴 졸리 배다캐무리 최적화 된 영양 지방산 조성
CN104173255A (zh) * 2014-08-11 2014-12-03 杨磊 舒缓止痒的平衡理肤水
CN107072276A (zh) * 2014-09-01 2017-08-18 马修·乔利·瓦达科姆里 一种优化的营养食品
WO2016078088A1 (zh) * 2014-11-21 2016-05-26 深圳华大基因科技有限公司 美藤果油在调节动物肠道菌群中的用途
CN104435907A (zh) * 2014-12-29 2015-03-25 河南天纳图生物科技有限公司 一种用于畜禽催肥的复方发酵型中药及其制备方法
US20160219921A1 (en) * 2015-02-04 2016-08-04 Natalja Klein Super food beverage
CN104740444A (zh) * 2015-04-07 2015-07-01 范永启 具有提神功效的复方精油喷雾剂
US20180139998A1 (en) 2015-05-04 2018-05-24 Enzymotec Ltd. Lipid compositions for improving sleep
CN106819153A (zh) * 2015-12-04 2017-06-13 金士力佳友(天津)有限公司 一种含美藤果油和深海鱼油的调和油及其应用
KR101744203B1 (ko) * 2016-01-12 2017-06-20 (주)노터스생명과학 포스파티딜콜린을 유효성분으로 포함하는 신장질환 예방 또는 치료용 약학 조성물
CA3014575A1 (en) * 2016-02-26 2017-08-31 Nogra Pharma Limited Methods of treating lactose intolerance
WO2017155898A1 (en) 2016-03-07 2017-09-14 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and exercise
JP7022955B2 (ja) 2016-03-17 2022-02-21 国立研究開発法人農業・食品産業技術総合研究機構 飲食物及びスクリーニング方法
CA3041829A1 (en) * 2016-10-31 2018-05-03 The Cleveland Clinic Foundation Capric acid and myristic acid compositions for treating conditions
JP7013645B2 (ja) * 2016-11-14 2022-02-15 日油株式会社 リパーゼ活性阻害剤
CN106942678A (zh) * 2017-03-06 2017-07-14 楚雄泰恒工贸有限责任公司 松露芝士核桃仁及其制备方法
MX2019013453A (es) 2017-05-12 2020-11-06 Housey Pharmaceutical Res Laboratories L L C Extractos de plantas con actividades antidiabeticas y otras actividades utiles.
NO344004B1 (en) * 2017-06-23 2019-08-12 Olivita As Combination of oils
CN107439888A (zh) * 2017-08-31 2017-12-08 广州赛莱拉干细胞科技股份有限公司 一种糖尿病人服用的组合物及其制备方法
CN107629863A (zh) * 2017-09-30 2018-01-26 三江县善茶轩工艺品有限公司 富硒茶籽油的制备方法
CN107858202B (zh) * 2017-11-17 2021-06-08 湖南日恋茶油股份有限公司 富硒茶油及其加工工艺
KR20200125966A (ko) * 2018-03-15 2020-11-05 유니버시티 오브 써던 캘리포니아 염증 및 ibd 병리의 역전을 촉진하는, 물만 섭취하는 금식이 아닌 금식 모방 식이요법 (fmd)
AU2019376681B2 (en) * 2018-11-09 2025-07-24 L-Nutra Inc. Nutrition bar for intermittent fasting-mimicking
EP4495101A3 (en) 2019-02-08 2025-04-30 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
WO2020165743A1 (en) * 2019-02-11 2020-08-20 Bhookhahaathi Hospitality Private Limited A nutraceutical composition for preventing bad breath and boosting immunity
WO2021207478A1 (en) * 2020-04-10 2021-10-14 The Procter & Gamble Company Compositions and methods for treating hot flashes
US11854684B2 (en) 2020-12-29 2023-12-26 Kpn Innovations, Llc. Methods and systems for nourishment refinement using psychiatric markers
CN112956543A (zh) * 2021-04-05 2021-06-15 江南大学 一种油脂组合物的调配方法
WO2024097724A2 (en) * 2022-11-04 2024-05-10 University Of Florida Research Foundation, Inc. A novel approach to interfere in the phenylpropanoid biosynthetic pathway to reduce pink-rib disorder in fresh lettuce
CN116421666B (zh) * 2023-04-07 2024-05-07 云南德彩堂生物医药科技有限公司 一种抗骨质疏松的油脂组合物，其制备方法及应用
CN120113746A (zh) * 2025-04-17 2025-06-10 武汉轻工大学 一种脂肪酸组合物、用途、母猪饲料

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784849A (en) * 1983-08-15 1988-11-15 Tutsky Ronald J Skin care and shaving compositions
JPH0353869A (ja) * 1989-07-21 1991-03-07 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸を含む食品
CA2023885C (en) * 1989-09-22 1996-02-27 Richard Worthington Lodge Low fat fried snack
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
US5578334A (en) * 1995-04-07 1996-11-26 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
US6630192B2 (en) * 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
CA2173780A1 (en) * 1995-06-01 1996-12-02 Randy Grote Method for providing nutrition in a variety of compositional forms
DE69630195T2 (de) * 1995-07-04 2004-08-12 Suntory Ltd. Verwendung eines ausgleichenden zusatzstoffes für omega-6 und omega-3 ungesättigte fettsäure
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US5635199A (en) * 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
TW360501B (en) * 1996-06-27 1999-06-11 Nestle Sa Dietetically balanced milk product
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6117476A (en) * 1999-01-04 2000-09-12 Shaul Eger Healthy food spreads
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
DE19948652A1 (de) 1999-10-01 2001-04-05 Yasmin Keschmiri Zusammensetzung aus Nahrungsmitteln, ihre Herstellung und ihre Verwendung als Aphrodisiakum und Vitaltonikum
CN1409606A (zh) * 1999-11-24 2003-04-09 Iams公司 增强犬和猫的繁殖性能的方法
RU2158514C1 (ru) 2000-04-03 2000-11-10 Болобан Леонид Григорьевич Масло льняное пищевое
JP2003534019A (ja) * 2000-06-01 2003-11-18 ユナイテッド フィーズ，インコーポレーテッド 動物飼料および方法
GB0016452D0 (en) * 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
EA006556B1 (ru) * 2001-03-27 2006-02-24 Те Риджентс Оф Те Юниверсити Оф Калифорния Способы, соединения и композиции для борьбы с ожирением и регулирования метаболизма жирных кислот
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
EP1285590A1 (en) * 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
JP4116844B2 (ja) * 2001-09-13 2008-07-09 花王株式会社 油脂組成物
US20030207971A1 (en) * 2001-11-27 2003-11-06 React Of Delafield Llc Emollient gel
IL147942A0 (en) * 2002-01-31 2002-08-14 Enzymotec Ltd Method of fractionation of phytosterol esters in oil and products obtained thereby
WO2003078574A2 (en) * 2002-03-11 2003-09-25 Lipomics Technologies, Inc. Novel metabolic targets and markers
US7090638B2 (en) * 2002-06-03 2006-08-15 Edward Vidgen System and method for optimized dietary menu planning
US20040001874A1 (en) * 2002-06-24 2004-01-01 Vital Living, Inc. Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
JP2005532394A (ja) * 2002-07-02 2005-10-27 ガリレオ ファーマシューティカルズ， インコーポレイティド 雌性被験体における炎症性症状および／またはバイオマーカーの低減のための組成物および方法
US20060275294A1 (en) * 2002-08-22 2006-12-07 Omoigui Osemwota S Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer
ATE407190T1 (de) * 2002-09-04 2008-09-15 Nestec Sa Verfahren zur herstellung von einem öl, das langkettige, mehrfach ungesättigte fettsäuren aus biomassen enthält, lebensmittel, nahrungsmittelzusammensetzung, kosmetische oder pharmazeutische zusammensetzung, die dieses ölenthält
US20060233863A1 (en) * 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
US7214491B2 (en) * 2003-05-07 2007-05-08 E. I. Du Pont De Nemours And Company Δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
DE10324548A1 (de) * 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
EP1510133A1 (en) * 2003-09-01 2005-03-02 Belovo S.A., Egg Science & Technology Balanced oil composition
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
DE10347970A1 (de) * 2003-10-09 2005-05-04 Broekelmann & Co Oelmuehle Gmb Speiseölmischung
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
US8052992B2 (en) * 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US20050130937A1 (en) * 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
CN1898370A (zh) * 2003-12-22 2007-01-17 湧永制药株式会社 油脂组合物
US7416752B2 (en) * 2004-01-06 2008-08-26 Sharp Ingrained Functional Foods, Inc. Method of fortifying seeds with an essential fatty acid, fortified seed and food product
US20060276373A1 (en) * 2004-01-23 2006-12-07 Bazan Nicolas G Neuroprotective complex for treatment of cerebral ischemia and injury
US8114906B2 (en) * 2004-04-16 2012-02-14 Abbott Products Gmbh Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease
US20080069932A1 (en) * 2004-04-28 2008-03-20 Kao Corporation Oil or Fat Composition
RU2351153C2 (ru) 2004-07-01 2009-04-10 Нестек С.А. Композиция диеты при остеоартрите собак
DE102004034640A1 (de) * 2004-07-16 2006-02-16 Institut für Molekular- und Systemmedizin Verfahren zur systemischen Biokorrektur eines Organismus
US7645795B2 (en) * 2004-09-21 2010-01-12 BodyBio, Inc Method for treating amyotrophic lateral sclerosis
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
ES2254018B2 (es) * 2004-11-16 2009-01-01 Universidad Autonoma De Madrid Mezcla oleosa de ingredientes bioactivos naturales para la preparacion de un producto alimenticio enriquecido.
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB2438574B (en) * 2005-03-14 2011-01-26 Sapporo Holdings Ltd Nutritionally balanced food or beverage product
CN101316521B (zh) * 2005-04-28 2014-06-25 恩兹默泰克有限公司 极性脂质混合物、其制备和应用
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
RU2305416C2 (ru) 2005-05-23 2007-09-10 Тихоокеанский Государственный Экономический Университет (Тгэу) Пищевая эмульсионная паста и способ ее получения
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US20070004639A1 (en) * 2005-07-01 2007-01-04 Bodybio, Inc. Methods and compositions for treating Parkinson's disease
US20070042008A1 (en) * 2005-08-18 2007-02-22 Bodybio, Inc. Compositions containing phosphatidylcholine and essential fatty acids
US20070082063A1 (en) * 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
BRPI0619598A2 (pt) * 2005-12-09 2011-10-11 Drugtech Corp composição de emulsão intravenosa de ácido graxo essencial e métodos de administração da mesma
CA2631220A1 (en) * 2006-01-09 2007-07-19 Nestec S.A. Treatment of stressed patients
US20080254017A1 (en) * 2006-06-19 2008-10-16 Bodybio, Inc. Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids
WO2008011272A2 (en) * 2006-07-21 2008-01-24 Novus International Inc. Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
KR101297921B1 (ko) * 2006-08-11 2013-08-19 카오카부시키가이샤 유지 조성물
US20080145506A1 (en) * 2006-12-18 2008-06-19 Bodybio, Inc. Food compositions and products containing balanced ratio of essential fatty acids
WO2008125380A1 (en) * 2007-04-11 2008-10-23 Unilever N.V. Edible fat continuous spreads
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US20100267826A1 (en) * 2009-04-20 2010-10-21 The Board Of Trustees Of The Leland Stanford Junior University Treatment of ischemic episodes and cerebroprotection through Prostaglandin E2 (PGE2) EP2 and/or EP4 receptor agonists

Also Published As

Publication number Publication date
WO2009131939A9 (en) 2010-05-06
US10292958B2 (en) 2019-05-21
MX2019010738A (es) 2019-11-05
MY157040A (en) 2016-04-15
IL208858A0 (en) 2011-01-31
JP2020127400A (ja) 2020-08-27
ZA201008232B (en) 2012-02-29
AU2009239499C1 (en) 2013-11-07
JP2014176385A (ja) 2014-09-25
EP2278885A4 (en) 2013-08-28
EP3305083A1 (en) 2018-04-11
CA2759551A1 (en) 2009-10-29
CN102065699A (zh) 2011-05-18
US20120100223A1 (en) 2012-04-26
EP2278885A2 (en) 2011-02-02
CO6321198A2 (es) 2011-09-20
JP7007010B2 (ja) 2022-01-24
IL208858A (en) 2017-12-31
AU2009239499A1 (en) 2009-10-29
KR102038118B1 (ko) 2019-10-29
JP6879597B2 (ja) 2021-06-02
KR102030851B1 (ko) 2019-10-10
MX2010011544A (es) 2010-12-20
EA201071206A1 (ru) 2011-08-30
US20090264520A1 (en) 2009-10-22
KR20110004447A (ko) 2011-01-13
JP2011518223A (ja) 2011-06-23
JP2018064563A (ja) 2018-04-26
AU2009239499B2 (en) 2013-03-21
BRPI0910852A2 (pt) 2018-05-29
WO2009131939A3 (en) 2010-03-11
KR20170129289A (ko) 2017-11-24
WO2009131939A2 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
CA2759551C (en) Lipid-containing compositions and methods of use thereof
JP2011518223A5 (enExample)
CN103260437B (zh) 优化的营养制剂、由其选择定制饮食的方法及其使用方法
CN107105745A (zh) 优化的营养脂肪酸组合物
ES2555032T3 (es) Compensación nutricional para dieta de tipo occidental
WO2007132714A1 (ja) 骨密度増加剤
HK1253786A1 (en) Lipid-containing compositions and methods of use thereof
Ara et al. A Systematic Review of Beneficial Outcomes of Omega-3 Fatty Acid in Human Musculoskeletal Diseases
MANSOR et al. Effect of various dietary pattern on blood pressure management: A review
AU2015275258A1 (en) Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof
Shahidi et al. Evening Primrose
primrose Oil THERAPEUTIC APPLICATIONS

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140327